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Abstract:  A concise approach has been developed for the total syntheses of tricladic acids A, B and C 
previously isolated from Tricladium castaneicola confirming the structures of these fungal natural 
products.  The required (E)-1,3-diene scaffolds were generated with complete stereocontrol via 
coupling of the appropriate nitronate with an unsaturated bromo-diester which was prepared in 2 
steps from citraconic anhydride. The reported structures of the anhydride waquafranone B and the 
parent diacid were synthesised leading to revision of the originally proposed structure of the natural 
product and, in accord with Sutherland, confirming that anhydrides with exo-dienes are unstable. 
Biomimetic dimerisations of the proposed monomers of the nonadride scytalidin were investigated. 
1. Introduction 
Maleidride natural products, characterised by a medium-ring carbocycle with at least one fused maleic 
anhydride moiety, are a large family of polyketide fungal metabolites which possess a range of 
herbicidal and fungicidal properties. Byssochlamic acid 1  from Byssochlamys fulva,1–6  and glauconic 
acid 2 and glaucanic acid 3 both from Penicillium glaucum  were amongst the first members of the 
family to be isolated.7,8 Since then many more nonadrides have been reported including cornexistin 4 
from Paecilomyces variotii which has generated significant interest as a potential wide-spectrum 
herbicide, due to its broad range of bioactivity and high tolerance by Zea mays.9,10 Scytalidin 5 isolated 
from Scytalidium album has been shown to be active against a wide-range of wood rotting pathogens, 
whilst higher plants are unharmed.11–13 In addition, the rubratoxins e.g. rubratoxin B 7 have been 
investigated for their anti-tumour properties.14 Further examples of nonadrides include castaneolide 








In 1965 Barton and Sutherland17 proposed that the biosynthesis of 1, 2 and 3 proceeds  via 
dimerisation of a C9- anhydride monomer with different substitution patterns on the core framework 
arising from either “head-to-tail” or “head-to head” couplings and was supported by the results of 
isotopic labelling studies.18,19 More recent work has focussed on  genome sequencing, knock out 
experiments and heterologous expression combined with isolation of intermediates leading to further 
insights into the biosynthesis of nonadrides.20–25  Using heterologous expression in Aspergillus oryzae 
we have shown that the precursors for cyclisation are formed by an iterative highly reducing 
polyketide synthase supported by a hydrolase together with citrate-processing enzymes (Scheme 1).    
Carboxylic acids such as 9 have been shown to undergo spontaneous decarboxylation, yielding 11,  
and both isomers 10 and 11 may be formed in this fashion.26 Various dimerisation modes of 9 (or the 
decarboxylated monomer 11) with either itself or with 10 may then give rise to the carbocyclic ring of 
the nonadrides, with different substitution patterns obtained.   
 
Scheme 1 Proposed biosynthesis of nonadrides and a biomimetic dimerisation 
Recreation of this dimerisation step in vitro is an attractive strategy for the total synthesis of 
nonadrides. Early work by Sutherland showed that treatment of 12 with Et3N in DMF could promote 
cyclisation giving iso-glaucanic acid 13 in 4% isolated yield,27 and this work was further developed by 
Baldwin using Et3N and MgCl2 in DMSO which gave 13  along with further products.28  Sulikowski 
tethered the two methylmaleic anhydride moieties together to enhance the efficiency of ring 
formation.29,30 In all cases, synthetic studies have focused on the homodimerisation of analogues of 
11. No studies have been reported on the proposed dimerisation pathways involving monomer 10 
with the exo-diene leading to scaffolds found in heveadride 8 or byssochlamic acid 1. This may be 
attributed, in part, to an early report from Sutherland which indicated that such compounds are 
unstable.27  
Pursuing an interest in the biosynthesis of maleidride natural products with fungicidal activities, herein 
we describe recent studies on the total syntheses of fungal dienoic acids tricladic acids A, B and C as 
well as the reported structure of waquafranone B isolated from Wicklowia aquatica and analogues of 




2. Results and Discussion 
2.1 Total synthesis of tricladic acids A, B and C  
In 2015, a series of natural products including maleic anhydride derivatives tricladolides A-D 14-17 
were isolated from the aquatic fungus Tricladium castaneicola.31 In addition, after an extensive 
purification protocol, three minor metabolites, tricladic acids A, B and C 18-20 were isolated and their 
structures tentatively assigned by spectroscopic methods and correlation with known compounds.  
The tricladic acids showed inhibitory activity against fungi such as Phytophthora sp. However, further 
investigations of their bioactivities were limited by both the difficulty in culturing aquatic 
hyphomycetes such as T. castaneicola,33,34 and the low titres of isolated natural products.  
 
Figure 2. Natural products isolated from T. castaneicola 
We devised a synthetic strategy to each of the target tricladic acids based on the nitronate additions 
to bromide 22 first reported by Amri for the preparation of similar 1,3-dienes.35  Bromide 22 was 
prepared in 2 steps and 69% yield from citraconic anhydride 21 by esterification followed by Wohl-
Ziegler bromination (Scheme 2). Reaction conditions were then optimised for the key coupling of 
bromide 22 and nitrohexane using different bases and solvents. The required diene 23 was isolated in 
60% yield as a single isomer using Et3N (4 equivalents) and slow addition of bromide 22 in THF:water 
(see ESI for full details). The E-geometry of the endo double bond of 23 was confirmed by NOESY 
studies (correlation between 5-H2 and 1-Ha) and an EXSIDE experiment36 which showed 3J(CH) 7.5 Hz in 
accord with a cis relationship between the ester carbonyl and 4-H.  Diester 23 was readily hydrolysed 
to the corresponding diacid 24 in 60% yield. 
 
    




This methodology was applied to the synthesis of each of the tricladic acids. Monobromination of 
octane 1,8-diol with HBr in toluene followed by displacement of the bromide with sodium nitrite gave 
the required alcohol 25 for the synthesis of tricladic acid C 20 (Scheme 2). Coupling 25 with bromide 
22 followed by hydrolysis of the resultant diester 26 gave diacid 20 with spectroscopic data in accord 
with that reported for the natural product.31  
Tricladolide C 16 isolated from T. castaneicola was racemic as determined by the Mosher’s method.  
By analogy, tricladic acid A 18 ([]D -0.4, c 0.35, MeOH) was presumed to be close to racemic but  not 
confirmed whilst tricladic acid B 19 was isolated as a 3:1 mixture of 9S:9R enantiomers, again 
determined by the Mosher’s method. We developed approaches for their total syntheses which could 
be readily adapted for the preparation of either enantiomer of the natural products as shown in 
Scheme 3.   A copper-catalysed addition of pent-4-enylmagnesium bromide to (S)-propylene oxide 
followed by acetylation of the resultant secondary alcohol gave unsaturated acetate 27. Protection of 
the alcohol was required for the next stage, to prevent oxidation to the corresponding ketone as 
reported by Hu and co-workers.37 The required (R)-nitro-acetate 28 was prepared in 54% yield using 
t-butyl nitrite and TEMPO followed by reduction with NaBH4. A similar approach was used for the 
synthesis of (S)-nitro-acetate 30 starting from (S)-1,2-epoxybutane and 3-butenyl magnesium bromide 
giving 30 in 44% yield over the 4 steps.  Reaction of bromide 22 separately with nitro-acetates 28 and 
30 under the optimised conditions gave, after hydrolysis of their resultant dimethyl esters, (R)-tricladic 
acid A 18, []D -5, c 0.91 MeOH, and (S)-tricladic acid B 19. The spectroscopic data of both were in 
accord with those reported for the natural products isolated from T. castaneicola. The specific rotation 
for synthetic (S)-tricladic acid B 19, []D +4, c 1.70, MeOH, was consistent with the proposal that the 
natural product was a 3:1 mixture of enantiomers in favour of the S enantiomer, []D +2, c 0.34, MeOH.  
 





2.2 Synthesis and structural revision of waquafranone B  
In 2010 analogues of heveadride 8 were isolated from the fungus Wicklowia aquatica along with the 
natural product waquafranone B 34 (Scheme 4).32 The structure was assigned by spectroscopic 
methods as an anhydride 34 with an exo-diene. However, whilst the reported HREIMS gave 
M+168.0786 in accord with the proposed molecular formula C9H12O3, the IR spectrum showed a 
carbonyl stretch at 1685 cm-1 rather than as expected for an anhydride (cf. carbonyl stretches of the 
anhydrides tricladolides A-D 14-17,  max ca. 1820 and 1770 cm-1) but more in accord with tricladic 
acids A, B and C 18-20 (max C=O, ca. 1695 cm-1 ). Thus, both diacid 33 and anhydride 34 were 
synthesised.  Coupling 1-nitrobutane with bromide 22 followed by hydrolysis of the resultant diester 
32 gave the required diacid 33. Treatment of 33 with AcCl/CH2Cl2 at -30 °C gave anhydride 34 which 
was unstable even when kept at -78 °C and after 96 h was converting to a mixture of products including 
maleic anhydride 12. This was in accord with Sutherland who had reported that such anhydrides are 
unstable.27 The 1H-NMR spectrum (CDCl3) of anhydride 34 displayed alkenic signals at  7.24, 6.59 and 
6.13 whereas for waquafranone B these were reported to resonate at  6.97, 6.45 and 5.62. The 1H-
NMR spectrum of diacid 33 was found to be pH dependent and in CDCl3 + 1 equivalent of DABCO gave 
alkenic signals at  6.96, 6.43 and 5.56 which correlated well with the natural product. Furthermore, 
the 13C-NMR, IR and MS data were fully consistent with the reported data and hence we conclude that 
waquafranone B is diacid 33.  
 
 
Scheme 4. Synthesis of diacid 33 and unstable anhydride 34 
2.3 Synthesis of proposed monomers for scytalidin biosynthesis and biomimetic dimerisations 
As anhydride 34 was unstable there was a concern that analogues may not be good substrates for the 
proposed “head-to-tail” dimerisations to byssochlamic acid 1 or scytalidin 5 scaffolds (Scheme 1) but 
the corresponding diacids or dimethyl esters may be alternatives. To examine the proposed “head-to-
tail dimerisation”, scytalidin monomer 38 was prepared by modification of the approach of Baldwin 
and co-workers (Scheme 5).38    Thus, a solvent-free hydroboration of hex-1-yne with catecholborane 
in the presence of dimethylacetamide gave catecholboronic ester 36 which was used without 
purification in a Suzuki coupling with the known38 iodide 35 to give diene 37. Hydrolysis of 37 and ring 
closure under acidic conditions gave the required maleic anhydride derivative 38. In a control reaction 
38 was treated with Et3N and MgCl2 in DMSO  for 16 hours at room temperature and iso-glaucanic 




was repeated using a 1:1 mixture of anhydride 38 and either dimethyl ester 23 or diacid 24,  
homodimerisation product 39 was isolated in similar yields as in the control experiment and the other 
component, either 23  or  24, was recovered unchanged. A similar result was achieved even when the 






    
  Scheme 5. Synthesis of maleic anhydride 38 and biomimetic dimerisations  




Next anhydride 40 with the exo -diene was prepared by treatment of diacid 24 with AcCl in CH2Cl2 at 
-30 oC and used immediately in the dimerisation reaction with maleic anhydride 38 at -30 °C giving a 
very complex mixture of products. Neither starting material (38 and 40) nor any clean products could 
be isolated.  
3. Conclusion 
In conclusion, a concise approach has been developed for the total syntheses of the tricladic acids A, 
B and C 16, 17 and 18 isolated from T. castaneicola confirming the structures of the natural products.  
Coupling the appropriate nitronate with bromide 22 generated the required (E)-1,3-diene scaffolds 
with complete stereocontrol. This approach was used for the synthesis of the reported structure, 
anhydride 34, of waquafranone B as well as the parent diacid 33 which led to reassignment of the 
structure of the natural product.   In accord with Sutherland, we found that anhydrides with an exo-
1,3-diene were unstable. Biomimetic “head-to-tail” dimerisations of monomer 38 with either diester 
23 or diacid 24 lead to homodimerisation of 38 giving isoglaucanic acid analogue 39 and recovered 23 
or 24 whereas reaction of 38 and 40 led to a complex mixture of products.  Such dimerisations would 





4. Experimental Section 
 
4.1 General Experimental 
All reagents were sourced from commercial suppliers and were used without further purification 
unless stated otherwise. All reactions using anhydrous solvents were performed using standard 
Schlenk syringe-septa techniques, with flame dried glassware under a positive pressure of nitrogen. 
Anhydrous THF, Et2O, hexane, toluene, acetonitrile and CH2Cl2 were dried by passing through a 
modified Grubbs system of alumina columns, manufactured by Anhydrous Engineering and stored 
over 3 Å molecular sieves. Dry DMF was obtained from Sigma-Aldrich, dry DMSO and acetone from 
Acros Organics, each were used without further purification or drying. Diisopropylamine and 
triethylamine were distilled over CaH2 prior to use in moisture-sensitive reactions. All stated 
temperatures below ambient are the temperatures of the cooling baths, unless otherwise stated. 
Flash column chromatography was performed according to the procedures used by Still et. al.39 using 
silica gel 60 (Fisher Scientific or Aldrich) and a suitable eluent. TLC analysis was performed with 
aluminium backed silica TLC plates (Merck-Kieselgel 60 F254) with a suitable solvent system and was 
visualised using UV fluorescence (254 & 366 nm) and/or developed with potassium permanganate 
solution. NMR spectra of 18 and 19 were obtained after purification by HPLC (Phenomenex 
Kinetex C18 column, 250 × 21.2 mm, 5 µm pore size), eluting with 20-60% acetonitrile in water with 
0.05% formic acid at 16 mL min-1. 
Infra-red spectra were recorded on a Perkin Elmer Spectrum 100 FTIR with an ATR accessory and 
frequencies are reported in wavenumbers (cm-1). 1H and 13C NMR spectra were recorded using Jeol 
ECS 400 MHz, Varian 400-MR (400 MHz), Varian VNMRS500a (500 MHz), Varian VNMRS500b (500 
MHz), Bruker Advance III HD 500 Cryo (500 MHz), Varian VNMR S600 Cryo (600 MHz), and Bruker 
Avance III HD 700 (1.7mm micro-cryo) (700 MHz) spectrometers at ambient temperature. Chemical 
shifts (δ) are quoted in parts per million (ppm) and coupling constants (J) are in Hertz (Hz), rounded to 
0.5 Hz intervals. Two-dimensional NMR techniques (HSQC, COSY, HMBC) were used routinely for 
structural assignment. Use of NOESY, TOCSY and EXSIDE techniques is indicated as appropriate. 
Residual solvent peaks were used as the internal reference for proton and carbon chemical shifts. 
HRMS ESI were performed on either a Bruker Daltonics Apex 4, 7 Tesla FTICR or microTOF II. Samples 
were submitted in MeOH or CH2Cl2. Specific rotations ([𝛼]𝐷
𝑇 ) were measured on a Bellingham and 
Stanley Ltd. ADP220 polarimeter and are quoted in (° ml)(g dm)-1. 
Dimethyl (E)-2-hexylidene-3-methylenesuccinate 23 
1-Nitrohexane (180 mg, 1.37 mmol) and triethylamine (440 mg, 4.3 mmol) were dissolved in a mixture 
of H2O (7 ml) and THF (7 ml). The solution was stirred for 2 h at room temperature. Allyl bromide 22 
(249 mg, 1.05 mmol) dissolved in THF (7 ml) was added over 2 hours at 0 °C. The resultant orange 
solution was stirred for 16 h at room temperature then diluted with water (10 ml). The aqueous layer 
was extracted with diethyl ether (3 × 75 ml). The organic extracts were combined and concentrated 
in vacuo. The residue was purified by column chromatography using ethyl acetate/petroleum ether 
(1-4% ethyl acetate) to give 23 as a colourless oil (152 mg, 60%).  δH (400 MHz, CDCl3) 6.99 (1H, t, J 7.0, 
4-H), 6.49 (1H, d, J 1.5, 1-HH), 5.58 (1H, d, J 1.5, 1-HH), 3.74 (3H, s, OCH3), 3.72 (3H, s, OCH3), 2.16 (2H, 
app. q, J 7.5, 5-H2), 1.48- 1.38 (2H, m, 6-H2), 1.33-1.23 (4H, m, 7-H2 and 8-H2), 0.87 (3H, m, 9-H3); δC 
(100 MHz, CDCl3) 166.9 (3-C=O), 166.6 (2-C=O), 146.7 (C-4), 135.4, 129.9 (C-2 and C-3), 129.5 (C-1), 
52.3 (OCH3), 52.1 (OCH3), 31.6 (C-7), 29.6 (C-5), 28.5 (C-6), 22.5 (C-8), 14.1 (9-H3); νmax (film) 2953, 2928, 





(E)-2-Hexylidene-3-methylenesuccinic acid 24 
Diester 23 (295 mg, 1.20 mmol) was dissolved in ethanol (12 mL) and sodium hydroxide (18 mL, 2 M) 
added. The reaction mixture was stirred at room temperature for 16 h, then aqueous sodium sulfate 
(4%, 25 mL) added and the reaction mixture acidified to pH 1 with hydrochloric acid (6 M). The aqueous 
mixture was extracted with diethyl ether (4 × 20 mL), and the combined organic layers dried over 
MgSO4, filtered, and concentrated in vacuo. The crude material was purified by column 
chromatography using ethyl acetate/petrol/acetic acid (25-40% ethyl acetate, 1% acetic acid) to yield 
diacid 24 as a white solid (158 mg, 60%). δH (400 MHz, MeOD) 6.95 (1H, t, J 7.5, 4-H), 6.44 (1H, s, 1-HH), 
5.60 (1H, s, 1-HH), 2.18 (2H, app. q, J 7.5, 5-H2), 1.46 (2H, m, 6-H2), 1.38-1.25 (4H, m, 7-H2 and 8-H2), 
0.90 (3H, t, J 6.5, 9-H3); δC (100 MHz, MeOD) 168.2 (C=O), 167.9 (C=O), 145.6 (C-4), 136.4 (C-3), 130.8 
(C-2), 128.3 (C-1), 31.2 (C-7), 29.0 (C-5), 28.0 (C-6), 22.0 (C-8), 12.9 (C-9); νmax (film) 2956, 2928, 2859, 
2650, 1683, 1620, 1426, 1281; HRMS (ESI) calc for C11H16NaO4 [M+Na]+ 235.0941, found 235.0930. 
Dimethyl (E)-2-(8-hydroxyoctylidene)-3-methylenesuccinate 26 
Nitroalkanol 25 (251 mg, 1.43 mmol, 1.3 equiv.) and triethylamine (0.54 mL, 0.39 g, 3.8 mmol, 3.5 
equiv.) were dissolved in THF (7.5 mL) and water (7.5 mL) and stirred for 2 h. Bromide 22 (263 mg, 
1.10 mmol, 1 equiv.) in THF (3 mL) was added at 0 ○C, and the reaction mixture stirred for an additional 
16 h at room temperature. The orange solution was diluted with water (20 mL) and extracted with 
diethyl ether (3 × 50 mL). The combined organic layers were dried over MgSO4, filtered, and 
concentrated in vacuo. The crude material was purified by column chromatography using ethyl 
acetate/petrol (25-50% ethyl acetate) to yield diester 26 (167 mg, 54%) as a colourless oil. δH (400 
MHz, CDCl3) 6.91 (1H, t, J 7.5, 4-H), 6.41 (1H, d, J 1.5, 1-HH), 5.51 (1H, d, J 1.5, 1-HH), 3.66 (3H, s, OCH3), 
3.64 (3H, s, OCH3), 3.51 (2H, t, J 6.5, 11-H2), 2.26 (1H, s, OH), 2.09 (2H, q, J 7.5, 5-H2), 1.46 (2H, m, 10-
H2), 1.36 (2H, p, J 7.0, 6-H2), 1.29-1.19 (6H, m, 7-H2, 8-H2, 9-H2); δC (100 MHz, CDCl3) 166.7 (3-C=O), 
166.4 (2-C=O), 146.5 (C-4), 135.1 (C-2), 129.7 (C-3), 129.5 (C-1), 62.6 (C-11), 52.1 (OCH3), 51.9 (OCH3), 
32.6 (C-10), 29.4 (C-5), 29.2, 29.1, 28.5, 22.6 (C-6, C-7, C-8 and C-9); νmax (film) 3515, 2931, 2857, 1714, 
1437, 1255, 908, 730; HRMS (ESI) calc for C15H24NaO5 [M+Na]+ 307.1516, found 307.1514. 
(E)-2-(8-Hydroxyoctylidene)-3-methylenesuccinic acid (Tricladic Acid C) 20 
Diester 26 (150 mg, 0.53 mmol) was dissolved in ethanol (15 mL) and sodium hydroxide (15 mL, 2 M) 
added. The reaction mixture was stirred at room temperature for 16 h, then aqueous sodium sulfate 
(4%, 40 mL) added and the reaction mixture acidified to pH 1 with hydrochloric acid (6 M). The aqueous 
mixture was extracted with diethyl ether (4 × 25 mL), and the combined organic layers dried over 
MgSO4, filtered, and concentrated in vacuo. The crude material was purified by column 
chromatography using ethyl acetate/petrol/acetic acid (75% ethyl acetate, 1% acetic acid) to give 
diacid 20 (120 mg, 90%) as a colourless oil. δH (400 MHz, MeOD) 6.92 (1H, t, J 7.5, 4-H), 6.42 (1H, d, J 
1.5, 1-HH), 5.57 (1H, d, J 1.5, 1-HH), 3.50 (2H, t, J 6.5, 11-H2), 2.16 (2H, q, J 7.5, 5-H2), 1.52-1.39 (4H, m, 
6-H2 and 10-H2), 1.38-1.22 (6H, m, 7-H2, 8-H2 and 9-H2); δC (100 MHz, MeOD) 169.6 (3-C=O), 169.3 (2-
C=O), 147.1 (C-4), 137.7 (C-2), 132.1 (C-3), 129.8 (C-1), 62.9 (C-11), 33.5 (C-10), 30.4 (C-5), 30.3, 30.2 
(C-7 and C-8), 29.6 (C-6), 26.7 (C-9); νmax (film) 2931, 2858, 2489, 2230, 2072, 1686, 1621, 1329, 1117, 
1056, 971; HRMS (ESI) calc for C13H19O5 [M-H]− 255.1238, found 255.1235. NMR data in accordance 
with literature of the isolated natural product.31 
(R)-2-Acetoxyoct-7-ene 27 
5-Bromo-1-pentene (4.6 mL, 5.80 g, 39 mmol) was dissolved in dry THF (30 mL). A small portion of 
which was added to a suspension of magnesium turnings (1.80 g, 75 mmol) in THF (45 mL) under a 




initiated, the remaining 5-bromo-1-pentene was added dropwise over 20 minutes. The reaction 
mixture was stirred for 1 h. The reaction mixture was cooled to −30 ˚C before CuI (150 mg, 0.78 mmol) 
was added. (R)-Propylene oxide (1.05 mL, 0.87 g, 15.0 mmol) was added and the reaction was warmed 
to −15 ˚C. The reaction was stirred for a further 2 h and then quenched with saturated aqueous NH4Cl 
(10 mL). After warming to room temperature, diethyl ether was added (30 mL) and the layers were 
separated. The organic layer was washed sequentially with water (30 mL) and brine (30 mL). The 
combined aqueous layers were extracted with diethyl ether (3 × 75 mL). The organic extracts were 
combined, dried over MgSO4 and concentrated in vacuo. The crude residue and acetyl chloride (2.10 
ml, 2.30 g, 30.0 mmol) were dissolved in diethyl ether (45 mL). Pyridine (2.4 mL, 2.4 g, 30 mmol) was 
added to the reaction mixture resulting in the formation of a white suspension. The solution was 
heated to reflux at 35 °C until TLC analysis (10% ethyl acetate, hexane) indicated that the starting 
material was consumed (1 h). After cooling the reaction mixture to room temperature, aqueous HCl 
(1 M, 40 mL) was added. The aqueous layer was separated and extracted with diethyl ether (3 × 75 
mL). The organic extracts were combined, dried over MgSO4, filtered, and concentrated in vacuo. The 
crude product was purified by column chromatography using petroleum ether/ethyl acetate (3% ethyl 
acetate) to give 27 as a colourless oil (2.10 g, 82%); [𝛼]D
22 = +3.0 (c 1.00, CHCl3); δH (400 MHz, CDCl3)  
5.73 (1H, ddt, J 17.0, 10.0, 6.5, 7-H), 4.93 (1H, dq, J 17.0, 2.0, 8-HH), 4.87 (1H, ddt, J 10.0, 2.0, 1.5, 
8-HH), 4.62 (1H, sext, J 6.0, 2-H), 1.98 (2H, m, 6-H2), 1.96 (3H, s, 10-H3), 1.54-1.21 (6H, m, 3-H2, 4-H2, 
5-H2), 1.13 (3H, d, J 6.0, 1-H3); δC (100 MHz, CDCl3) 170.8 (C-9), 138.7 (C-7), 114.4 (C-8), 71.0 (C-2), 35.7 
(C-3), 33.6 (C-6), 28.7 (C-5), 24.8 (C-4), 21.4 (C-10), 20.0 (C-1); νmax (film) 3074, 2977, 2932, 1735, 1640, 
1240; HRMS (ESI) calc for C10H18O2Na [M+Na]+ 193.1199, found 193.1194. 
(R,E)-2-Acetoxy-8-nitrooct-7-ene  
Acetylated alcohol 27 (1.20 g, 7.00 mmol), tert-butyl nitrite (1.80 mL, 1.60 g, 15.0 mmol) and TEMPO 
(268 mg, 1.72 mmol) were dissolved in 1,4-dioxane (18 mL) and heated to reflux in air at 90 °C for 16 
h. The orange solution was washed through a Celite® pad, concentrated in vacuo and purified by 
column chromatography using petroleum ether/diethyl ether (14-25% diethyl ether) to give the title 
compound as an orange oil (1.16 g, 77%). [𝛼]D
22 = +14 (c. 1.00, CHCl3); δH (400 MHz, CD2Cl2) 7.18 (1H, 
dt, J 13.0, 7.0, 7-H), 6.91 (1H, dt, J 13.0, 1.5, 8-H), 4.78 (1H, sext, J 6.5, 2-H), 2.19 (2H, qd, J 7.0, 1.5, 6-
H2), 1.91 (3H, s, 10-H3), 1.55-1.25 (6H, m, 3-H2, 4-H2, 5-H2), 1.10 (3H, d, J 6.0, 1-H3); δC (100 MHz, CD2Cl2) 
170.4 (C-9), 142.6 (C-7), 139.6 (C-8), 70.4 (C-2), 35.4 (C-3), 28.3 (C-6), 27.5 (C-5), 24.8 (C-4), 21.1 (C-
10), 19.7 (C-1); νmax (film) 2977, 2936, 1729, 1648, 1522, 1351, 1242; HRMS (ESI) calc for C10H17NO4Na 
[M+Na]+ 238.1055, found 238.1056. 
(R)-2-Acetoxy-8-nitrooctane 28 
To a solution of the above nitroalkene (400 mg, 1.86 mmol) in THF:methanol (10:1, 18 mL) at 0 °C 
under a nitrogen atmosphere, NaBH4 (140 mg, 3.72 mmol) was added in five portions. The reaction 
was stirred for 1 h at 0 °C. the resultant orange solution was quenched with saturated aqueous 
NaHCO3 (5 mL), diluted with water (50 mL) and extracted with ethyl acetate (4 × 50 mL). The combined 
organic layers were washed with brine (10 mL), dried over MgSO4, filtered, and concentrated in vacuo. 
The residue was purified by column chromatography using hexane/ethyl acetate (12% ethyl acetate) 
to give nitroalkane 28 as a colourless oil (284 mg, 70%). [𝛼]D
22 = +21 (c 0.66, CHCl3); δH (400 MHz, CDCl3) 
4.88 (1H, sext, J 6.5, 2-H), 4.37 (2H, t, J 7.5, 8-H2), 2.02 (3H, s, 10-H3), 2.00 (2H, quin, J 7.5, 7-H2), 1.60-
1.27 (8H, m, 3-H2, 4-H2, 5-H2, 6-H2), 1.20 (3H, d, J 6.5, 1-H3); δC (100 MHz, CDCl3) 170.8 (C-9), 75.6 (C-
8), 70.8 (C-2), 35.7 (C-3), 28.6 (C-5), 27.3 (C-7), 26.1 (C-6), 25.0 (C-4), 21.4 (C-10), 20.0 (C-1); νmax (film) 





Dimethyl (R,E)-2-(6-acetoxyheptylidene)-3-methylenesuccinate 29 
Nitroalkane 28 (200 mg, 0.92 mmol) and triethylamine (0.58 mL, 0.42 g, 4.10 mmol) were dissolved in 
THF (8 mL) and water (8 mL). The solution was stirred for 2 h at room temperature. Allyl bromide 22 
(175 mg, 0.74 mmol) in THF (2 mL) was added over 2 h at 0 °C with a syringe pump and stirred for an 
additional 16 h at room temperature. The yellow solution was diluted with water (30 mL) and 
extracted with diethyl ether (4 × 75 mL). The combined organic extracts were dried over MgSO4, 
filtered, and concentrated under reduced pressure. The crude material was purified by column 
chromatography using petroleum ether/ethyl acetate (9-17% ethyl acetate) to give triester 29 as a 
colourless oil (150 mg, 65%). [𝛼]D
22 = +16 (c 0.66, CHCl3); δH (400 MHz, CDCl3) 6.97 (1H, t, J 7.5, 4-H), 
6.49 (1H, d, J 1.5, 1-HH), 5.57 (1H, d, J 1.5, 1-HH), 4.85 (1H, sext, J 6.5, 10-H), 3.74 (3H, s, OCH3), 3.71 
(3H, s, OCH3), 2.16 (2H, q, J 7.5, 5-H2), 2.01 (3H, s, 13-H3), 1.59-1.38 (4H, m, 7-H2, 9-H2), 1.34-1.25 (4H, 
m, 6-H2, 8-H2), 1.18 (3H, d, J 6.5, 11-H3); δC (100 MHz, CDCl3) 170.7 (C-12), 166.7 (3-C=O), 166.4 (2-C=O), 
146.2 (C-4), 135.2 (C-2), 129.9 (C-3), 129.4 (C-1), 70.9 (C-10), 52.2 (2-OCH3), 52.0 (3-OCH3), 35.8 (C-9), 
29.4 (C-5), 29.1 (C-6), 28.5 (C-7), 25.1 (C-8), 21.4 (C-13), 19.9 (C-11); νmax (film) 2934, 2859, 1721, 1623, 
1242, 1199; HRMS (ESI) calc for C17H26O6Na [M+Na]+ 349.1627, found 349.1625. 
(R,E)-2-(6-Hydroxyheptylidene)-3-methylenesuccinic acid (Tricladic acid A) 18 
Triester 29 (140 mg, 0.45 mmol) was dissolved in ethanol (5 mL) and added to aqueous sodium 
hydroxide (10 mL, 2 M) at 0 °C over 20 minutes. The solution was stirred at room temperature for 16 
h. The reaction mixture was acidified to pH 1 with aqueous HCl (6 M). The solution was extracted 
with diethyl ether (4 × 50 mL). The combined organic extracts were dried over MgSO4, filtered, and 
concentrated under reduced pressure. The crude material was purified by flash column 
chromatography using petroleum ether/ethyl acetate/acetic acid (70% ethyl acetate, 0.8% acetic 
acid) to give (R)-18 as a viscous oil (115 mg, 56%). [𝛼]D
22 = −5 (c. 0.91, MeOH) [lit. [𝛼]D
20 −0.4 (c 0.35, 
MeOH)]31; δH (400 MHz, CH3OD) 6.96 (1H, t, J 7.5, 4- H), 6.43 (1H, d, J 1.5, 1-HH), 5.59 (1H, d, J 1.5, 1-
HH), 3.70 (1H, m, 10-H), 2.21 (2H, q, J 7.5, 5-H2), 1.50-1.25 (8H, m, 6-H2, 7-H2, 8-H2, 9-H2), 1.14 (3H, d, 
J 6.0, 11-H3); δC (100 MHz, CH3OD) 168.6 (3-C=O), 168.3 (2-C=O), 145.3 (C-4), 136.9 (C-2), 131.2 (C-3), 
128.0 (C-1), 67.1 (C-10), 38.6 (C-9), 29.1 (C-5), 29.0 (C-7), 28.3 (C-6), 25.2 (C-8), 22.1 (C-11); νmax (film) 
3385, 2931, 2858, 1693, 1621, 1279, 1130; HRMS (ESI) calc for C13H20O5Na [M+Na]+ 279.1208, found 
279.1208. 1H and 13C spectra obtained after further purification by preparative HPLC, and is in 
accordance with literature.31 
 (S,E)-3-Acetoxy-8-nitrooct-7-ene  
(S)-3-Acetoxyoct-7-ene  (1.35 g, 7.93 mmol), tert-butyl nitrite (2.0 mL, 1.2 g, 16.0 mmol) and TEMPO 
(513 mg, 3.28 mmol) were dissolved in 1,4-dioxane (20 mL) and heated to reflux in air at 90 °C for 16 
h. The orange solution was washed through a Celite® pad, concentrated in vacuo, and purified by 
column chromatography using petroleum ether/diethyl ether (14-25% diethyl ether) to give the title 
compound as an orange oil (1.18 g, 69%). [𝛼]D
22 = −11 (c. 1.00, CHCl3); δH (400 MHz, CDCl3) 7.17 (1H, 
dt, J 13.5, 7.5, 7-H), 9.91 (1H, dt, J 13.5, 1.5, 8-H), 2.20 (2H, m, 6-H2), 1.94 (3H, s, 10-H3), 1.53-1.39 (6H, 
m, 2-H2, 4-H2, 5-H2), 0.80 (3H, t, J 7.5, 1-H3) δC (100 MHz, CDCl3) 170.6 (C-9), 142.3 (C-7), 139.8 (C-8), 
74.5 (C-3), 33.0 (C-4), 28.2 (C-6), 27.0 (C-2), 23.6 (C-5), 20.7 (C-10), 9.3 (C-1); νmax (film) 2939, 2878, 
1728, 1649, 1522, 1351, 1241; HRMS (ESI) calc for C10H17NO4Na [M+Na]+ 238.1055, found 238.1057. 
(S,E)-3-Acetoxy-8-nitrooctane 30 
To a solution of the above nitroalkene (1.00 g, 4.60 mmol) in THF:methanol (10:1, 45 mL) at 0 °C under 
a nitrogen atmosphere, NaBH4 (263 mg, 6.97 mmol) was added in five portions. The reaction was 




diluted with water (100 mL) and extracted with ethyl acetate (4 × 75 mL). The combined organic layers 
were washed with brine (30 mL), dried MgSO4, filtered, and concentrated in vacuo. The residue was 
purified by column chromatography using hexane/ethyl acetate (10-12% ethyl acetate) to give 
nitroalkane 30 as a colourless oil (706 mg, 70%). [𝛼]D
22 = −11 (c 1.00, CHCl3); δH (400 MHz, CDCl3) 4.73 
(1H, quin, J 6.0, 3-H), 4.31 (2H, t, J 7.0, 8-H2), 1.98 (3H, s, 10-H3), 1.94 (2H, quin, J 7.5, 7-H2), 1.55-1.42 
(4H, m, 2-H2, 4-H2), 1.38-1.22 (4H, m, 5-H2, 6-H2), 0.81 (3H, t, J 7.5, 1-H3); δC (100 MHz, CDCl3)  170.9 
(C-9), 75.5 (C-8), 75.0 (C-3), 33.3 (C-4), 27.3 (C-7), 27.0 (C-2), 26.1 (C-6), 24.6 (C-5), 21.2 (C-10), 9.6 (C-
1); νmax (film) 2938, 2864, 1727, 1550, 1372, 1241;  HRMS (ESI) calc for C10H19NO4Na [M+Na]+ 240.1212, 
found 240.1208. 
Dimethyl (S, E)-2-(5-acetoxyheptylidene)-3-methylenesuccinate 31 
Nitroalkane 30 (300 mg, 1.38 mmol, 1.1 equiv.) and triethylamine (0.87 mL, 0.63 mg, 6.20 mmol, 5 
equiv.) were dissolved in THF (12 mL) and water (12 mL). Following 2 h of stirring a red solution was 
observed. Bromide 22 (285 mg, 1.20 mmol) in THF (3 mL) was added over 2 h at 0 °C with a syringe 
pump and stirred for an additional 14 h at room temperature. The yellow solution was diluted with 
water (40 mL) and extracted with diethyl ether (4 × 75 mL). The combined organic extracts were dried 
over MgSO4, filtered, and concentrated in vacuo. The crude material was purified by column 
chromatography using petroleum ether/ethyl acetate (9-17% ethyl acetate) to give triester 31 as a 
colourless oil (266 mg, 71%). [𝛼]D
22 = −8 (c 1.00, CHCl3); δH (400 MHz, CDCl3) 6.97 (1H, t, J 7.5, 4-H), 
6.49 (1H, d, J 1.5, 1-HH), 5.56 (1H, d, J 1.5, 1-HH), 4.78 (1H, quin, J 6.0, 9-H), 3.74 (3H, s, OCH3), 3.72 
(3H, s, OCH3), 1.56-1.40 (6H, m, 6-H2, 8-H2, 10-H2), 1.36-1.23 (2H, m, 7-H2), 0.86 (3H, t, J 7.5, 11-H3); δC 
(100 MHz, CDCl3) 170.9 (C-12), 166.7 (C=O), 166.4 (C=O), 146.0 (C-4), 135.2 (C-2), 130.0 (C-3), 129.5 
(C-1), 75.2 (C-9), 52.2, 52.0 (2-OCH3 and 3-OCH3), 33.3 (C-8), 29.4 (C-5), 28.5 (C-6), 27.0 (C-10), 25.1 (C-
7), 21.2 (C-13), 9.6 (C-11); νmax (film) 2948, 2860, 1721, 1623, 1240; HRMS (ESI) calc for C17H26O6Na 
[M+Na]+ 349.1627, found 349.1632. 
(S,E)-2-(6-Hydroxyoctylidene)-3-methylenesuccinic acid ((S)-Tricladic acid B) 19 
Triester 31 (210 mg, 0.67 mmol) was dissolved in ethanol (7 mL) and added to aqueous sodium 
hydroxide (14 mL, 2 M) at 0 °C over 0.3 h. The solution was stirred at room temperature for 16 h. The 
reaction mixture was acidified to pH 1 with aqueous hydrochloric acid (6 M). The solution was 
extracted with ethyl acetate (4 × 75 mL). The combined organic extracts were dried over MgSO4, 
filtered, and concentrated in vacuo. The crude material was purified by flash column chromatography 
using petroleum ether/ethyl acetate/acetic acid (70% ethyl acetate, 0.8% acetic acid) to give 19 as a 
viscous oil (124 mg, 72%).  [𝛼]D
22 = +4 (c. 1.70, MeOH); δH (400 MHz, CDCl3) 6.96 (1H, t, J 7.5, 4-H), 6.44 
(1H, d, J 1.5, 1-HH), 5.61 (1H, d, J 1.5, 1-HH), 3.43 (1H, m, 9-H), 2.21 (2H, q, J 7.5, 5-H2), 1.50-1.25 (8H, 
m, 6-H2, 7-H2, 8-H2, 10-H2), 1.14 (3H, t, J 7.5, 11- H3); δC (100 MHz, CDCl3) 168.4 (3-C=O), 168.1 (2-C=O), 
145.4 (C-4), 136.7 (C-2), 131.0 (C-3), 128.2 (C-1), 72.3 (C-9), 36.2 (C-8), 29.7 (C-10), 29.1 (C-5), 28.4 (C-
6), 25.1 (C-7), 9.0 (C-11); νmax (film) 3371, 2933, 2860, 1691, 1622, 1266, 1129; HRMS (ESI) calc for 
C13H20O5Na [M+Na]+ 279.1208, found 279.1205. 1H and 13C spectra obtained after further purification 
by preparative HPLC, and is in accordance with literature for the natural product.31 
Dimethyl (E)-2-butylidene-3-methylenesuccinate 32 
1-Nitrobutane (425 mg, 4.11 mmol, 1.3 equiv.) and triethylamine (2.20 mL, 1.60 g, 15.8 mmol, 5 equiv.) 
were dissolved in THF (20 mL) and water (20 mL) and stirred for 2 h. The reaction mixture was cooled 
to 0 °C, bromide 22 (750 mg, 3.21 mmol) in THF (7 mL) was added over 8 h, and then the reaction 
mixture stirred for an additional 16 h. The orange solution was diluted with water (20 mL) and 




and concentrated in vacuo. The crude material was purified by column chromatography using ethyl 
acetate/petrol (1-4% ethyl acetate) to give diester 32 as a colourless oil (314 mg, 47%). δH (400 MHz, 
CDCl3) 6.97 (1H, t, J 7.5, 4-H), 6.46 (1H, d, J 1.5, 1-HH), 5.55 (1H, d, J 1.5, 1-HH), 3.71 (3H, s, OCH3), 3.69 
(3H, s, OCH3), 2.12 (2H, q, J 7.5, 5-H2), 1.44 (2H, q, J 7.5, 6-H2), 0.89 (3H, t, J 7.5, 7-H3); δC (100 MHz, 
CDCl3) 166.8 (C=O), 166.5 (C=O), 146.4 (C-4), 135.3 (C-3), 130.0 (C-2), 129.5 (C-1), 52.2 (OCH3), 52.0 
(OCH3), 31.6 (C-5), 22.0 (C-6), 13.9 (C-7); νmax (film) 3416, 2959, 1935, 1719, 1459, 1145; HRMS (ESI) 
calc for C11H16NaO4 [M+Na]+ 235.0941, found 235.0945. 
(E)-2-Butylidene-3-methylenesuccinic acid 33 
To a solution of diester 32 (500 mg, 2.4 mmol) in water (40 mL) and THF (40 mL) was added lithium 
hydroxide (1.13 g, 47 mmol, 20 equiv.). The reaction mixture was heated to 50 °C for 16 h, then cooled 
to room temperature. Saturated aqueous NaHCO3 solution (15 mL) was added, then the reaction 
mixture was extracted with diethyl ether (3 × 20 mL). The aqueous layer was acidified to pH 4 with 
solid citric acid, then extracted with diethyl ether (4 × 20 mL). The combined organic layers were then 
extracted with water (5 × 20 mL), dried over MgSO4, filtered, and concentrated in vacuo to give diacid 
33 as an amorphous white solid (388 mg, 89%). δH (400 MHz, CDCl3) 7.14 (1H, t, J 7.5, 4-H), 6.62 (1H, 
d, J 1.5, 1-HH), 5.71 (1H, d, J 1.5, 1-HH), 2.20 (2H, q, J 7.5, 5-H2), 1.49 (2H, q, J 7.5, 6-H2), 0.93 (3H, t, J 
7.5, 7-H3); δC (125 MHz, CDCl3) 171.9 (C=O), 171.7 (C=O), 149.0 (C-4), 134.8 (C-3), 131.5 (C-3), 129.5 
(C-1), 31.8 (C-5), 22.0 (C-6), 14.0 (C-7); νmax (film) 2963, 2660, 2570, 1675, 1624, 1436, 1295, 1145; 
HRMS (ESI) calc for C9H12O4 [M-H]− 183.0663, found 188.0659. 
NMR on addition of 0.5 eq. of DABCO: δH (500 MHz, CDCl3) 6.96 (1H, t, J 7.5, 4-H), 6.43 (1H, d, J 1.5, 1-
HH), 5.56 (1H, d, J 1.5, 1-HH), 2.19 (2H, q, J 7.5, 5-H2), 1.46 (2H, q, J 7.5, 6-H2), 0.92 (3H, t, J 7.5, 7-H3); 
δC (125 MHz, CDCl3) 171.6 (C=O), 171.2 (C=O), 146.7 (C-4), 137.1 (C-3), 131.5 (C-2), 129.2 (C-1), 31.7 
(C-5), 22.2 (C-6), 14.0 (C-7). 
 
(E)-3-Butylidene-4-methylenedihydrofuran-2,5-dione 34 
Diacid 33 (75 mg, 0.41 mmol) in dry DCM (2 mL) was cooled to −20 °C, then acetyl chloride (0.1 mL, 6 
equiv.) added dropwise. The temperature was maintained at −20 °C for 96 h, after which the solvent 
was removed under first a stream of N2 then in vacuo, maintaining an internal temperature of −30 °C. 
Pre-cooled CDCl3 (2 mL) was added, with an aliquot (0.8 mL) then removed after 0.25 h for NMR 
analysis. δH (500 MHz, CDCl3) 7.24 (1H, t, J 7.5, 4-H), 6.59 (1H, s, 1-HH), 6.13 (1H, s, 1-HH), 2.52 (2H, q, 
J 7.5, 5-H2), 1.68 (2H, q, J 7.5, 6-H2), 1.04 (3H, t, J 7.5, 7-H3); δC (125 MHz, CDCl3) 163.9 (C=O), 163.8 
(C=O), 149.3 (C-4), 130.4 (C-3), 125.3 (C-1), 122.3 (C-2), 32.0 (C-5), 21.6 (C-6), 14.0 (C-7). Compound 
rapidly decomposes to multiple products. IR and MS could not be collected. 
 (E)-2-(Hex-1-en-1-yl)benzo[d][1,3,2]dioxaborole 36 
1-Hexyne (3.5 mL, 2.50 g, 30.5 mmol) was dissolved in THF (5 mL) and N,N-dimethylacetamide (0.2 
mL) added. Catecholborane (3.9 mL, 3.67 g, 30.5 mmol, 1 equiv.) was added dropwise, and then the 
reaction heated to reflux for 3 h. The reaction mixture was cooled to room temperature, concentrated 
in vacuo, then purified by column chromatography using ethyl acetate/petrol (10-50% ethyl acetate) 
to give catecholboronic ester 36 as a yellow oil (4.22 g, 69%). δH (400 MHz, CDCl3) 7.24-7.20 (2H, m, 
Ar-H),  7.10-7.05 (2H, m, Ar-H), 6.86 (1H, m, 2-H), 5.80 (1H, dd, J 18.0, 1.5, 1-H), 2.30 (2H, tdd, J 8.0, 
6.0, 1.5, 3-H2) 1.54-1.45 (2H, m, 4-H2), 1.44-1.35 (2H, m, 5-H2), 0.94 (3H, t, J 7.5, 6-H3); δC (100 MHz, 
CDCl3) 158.2 (C-2), 148.4 (Ar), 122.6 (Ar), 121.4 (C-1), 115.6 (C-1), 112.4 (Ar), 35.9 (C-3), 30.4 (C-4), 





Diethyl 2-((E)-hex-1-en-1-yl)-3-methylmaleate 37 
Potassium carbonate (1.60 g, 11.5 mmol, 1.8 equiv.), triphenylphosphine (110 mg, 0.42 mmol, 0.08 
equiv.) and palladium(II) acetate (47 mg, 0.20 mmol, 0.03 equiv.) were dissolved in absolute ethanol 
(40 mL). Solutions of unpurified vinyl iodide 35 (2.84 g) and boronic ester 36 (1.566 g) each in ethanol 
(10 mL) were added sequentially, and the resulting dark brown suspension was heated to reflux at 80 
○C for 16 h. The dark mixture was then cooled to room temperature, poured into water (30 mL) and 
extracted with diethyl ether (3 × 50 mL). The combined organic layers were washed with water (2 × 
25 mL) and brine (30 mL), dried over MgSO4, filtered, and concentrated in vacuo.  The crude material 
was purified by column chromatography using diethyl ether/petrol (5-20% diethyl ether) to give 
diester 37 (1.012 g, 40% over two steps). δH (400 MHz, CDCl3) 6.31 (1H, dt, J  16.0, 1.5 Hz, 4-H), 5.94 
(1H, dt, J 16.0, 7.0 Hz, 5-H), 4.29 (2H, q, J 7.0 Hz, OCH2), 4.17 (2H, q, J 7.0 Hz, OCH2), 2.18 (2H, q, J 7.0, 
6-H2), 1.97 (3H, s, 1-H3), 1.44-1.35 (2H, m, 7-H2), 1.34-1.23 (8H, m, 8-H2, 2 × OCH2CH3), 0.88 (3H, t, J 
7.0, 9-H3); δC (100 MHz, CDCl3) 169.1 (C=O), 167.2 (C=O), 141.5 (C-2), 141.1 (C-4), 124.2 (C-3), 124.0 
(C-5), 61.2 (OCH2), 61.1 (OCH2), 33.4 (C-6), 30.9 (C-7), 22.3 (C-8), 14.2 (OCH2CH3), 14.2  (OCH2CH3), 13.9 
(C-9), 13.6 (C-1); νmax (film) 2981, 2932, 1721, 1368, 1259, 1181, 1108, 1033; ; HRMS (ESI) calc for 
C15H24NaO4 [M+Na]+ 291.1567, found 291.1571.  
(E)-3-Methyl-4-(hex-1-en-1-yl)furan-2,5-dione 38 
Diester 37 (750 mg, 2.8 mmol) was dissolved in ethanol (35 mL) and sodium hydroxide (2 M, 45 mL) 
added. The resulting solution was stirred at room temperature for 16 h, then sodium sulfate (4%, 50 
mL) added and the reaction mixture acidified to pH 1 with hydrochloric acid (6 M). The aqueous 
mixture was extracted with diethyl ether (4 × 50 mL), and the combined organic layers washed with 
water (50 mL), then dried over MgSO4, filtered, and then concentrated in vacuo to give maleic 
anhydride 38 (1.49 g, 91%). δH (400 MHz, CDCl3) 7.12 (1H, dt, J 16.0, 7.0, 5-H), 6.23 (1H, dt, J 16.0, 1.5, 
4-H), 2.28 (2H, qd, J 7.0, 1.5, 6-H2), 2.11 (3H, s, 1-H3), 1.53-1.43 (2H, m, 7-H2), 1.41-1.31 (2H, m, 8-H2), 
0.92 (3H, t, J 7.5, 9-H3); δ C(100 MHz, CDCl3) 166.5 (C=O), 164.7 (C=O), 148.2 (C-5), 137.4 (C-3), 135.0 
(C-2), 117.3 (C-4), 34.3 (C-6), 30.7 (C-7), 22.4 (C-8), 14.0 (C-9), 9.4 (C-1); HRMS (ESI) calc for C11H14NaO3 
[M+Na]+ 217.0835, found 217.0840.  
(±)-(5S,6S,10aR,E)-5,6-dibutyl-10a-methyl-5,6,10a,11-tetrahydro-1H-cyclonona[1,2-c:4,5-c']difuran-
1,3,8,10(4H)-tetraone 39 
To MgCl2 (13 mg, 0.14 mmol, 0.5 equiv.) in dry DMSO (3.6 mL) was added anhydride 38 (50 mg, 0.26 
mmol) and triethylamine (23 μL, 17 mg, 0.17 mmol, 0.65 equiv.). The purple solution was stirred at 
room temperature for 16 h, then quenched by the addition of hydrochloric acid (5 mL, 3 M). The 
orange solution was extracted with diethyl ether (3 × 20 mL), then the combined organic layers were 
washed with water (20 mL) and brine (20 mL). After drying over MgSO4, filtration, and concentration 
in vacuo, the crude material was purified by column chromatography using diethyl 
ether/petrol/formic acid (10-30% ethyl acetate, 2% formic acid) to give 39 as a yellow oil (5 mg, 10%). 
δH (500 MHz, CDCl3) 6.93 (1H, d, J 11.5, 6-H), 3.26 (1H, d, J 13.5, 9-HH), 2.77 (1H, dd, J 13.5,  3.5, 12-
HH), 2.63 (1H, d, J 13.5, 9-HH), 2.35 (1H, dd, J 13.5, 5.0, 12-HH), 1.99-1.86 (2H, m, 5-H and 13-H), 1.75-
1.60 (2H, m, 4-HH and 14-HH), 1.53 (3H, s, 18-H3), 1.38-1.12 (10H, m, 4-HH, 14-HH, 2-H2, 3-H2, 15-H2, 
16-H2), 0.97 (3H, t, J 7.5, 1-H3), 0.86 (3H, t, J 7.5, 17-H3); δC (125 MHz, CDCl3) 173.8 (C=O), 165.6 (C=O), 
165.3 (C=O), 164.2 (C=O), 152.3 (C-6), 147.3 (C-10), 141.4 (C-11), 129.9 (C-7), 48.8 (C-8), 43.1 (C-5), 
32.9 (C-9), 31.7 (C-4), 30.3 (C-15), 30.2 (C-3), 29.6 (C-14), 23.2 (C-16), 22.9 (C-2), 20.3 (C-18), 14.2 (C-






Diacid 24 (55 mg, 0.25 mmol) in dry DCM (2 mL) was cooled to −30 °C, then acetyl chloride (0.1 mL, 6 
equiv.) added dropwise. The temperature was maintained at −30 °C for 96 h, after which the solvent 
was removed under first a stream of N2 then in vacuo, maintaining an internal temperature of −30 °C. 
Pre-cooled carbon tetrachloride (2 mL) was added, with an aliquot (0.8 mL) then removed after 0.25 
h for NMR analysis. The remaining solution was concentrated in vacuo at −30 °C and used immediately 
without further purification. δH (500 MHz, CCl4) 7.10 (1H, br. s, 4-H), 6.50 (1H, br. s, 1-HH), 6.04 (1H, 
br. s, 1-HH), 2.70-1.90 (2H, m, 5-H2), 1.75-1.08 (6H, m, 6-H2, 7-H2, 8-H2), 1.00-0.76 (3H, m, 9-H3); δC 
(125 MHz, CCl4) 162.3 (C=O), 162.2 (C=O), 147.1 (C-4), 130.7 (C-3), 123.4 (C-1), 122.4 (C-2), 31.4 (C-6, 
C-7 or C-8), 29.6 (C-5), 27.7 (C-6, C-7 or C-8), 22.3 (C-6, C-7 or C-8), 13.8 (C-9); δH (400 MHz, CDCl3) 7.21 
(1H, t, J 7.0, 4-H), 6.56 (1H, s, 1-HH), 6.12 (1H, s, 1-HH), 2.52 (2H, q, J 7.0, 5-H2), 1.66-1.57 (2H, m, CH2), 
1.40-1.20 (4H, m, 2 × CH2), 0.93-0.85 (3H, m, 9-H3) Compound rapidly decomposes to multiple products, 
including 38. IR and MS could not be collected. 
Acknowledgements We are grateful to the EPSRC (EP/L015366/1), Bristol Chemical Synthesis Centre 
for Doctoral Training, which provided a PhD studentship for DMH. 
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